Johan Lennerstrand

Twist-ONT: Combining nanopore sequencing with the twist comprehensive viral research panel

Haars, Jonathan; Cumlin, Tomas; Ladenvall, Claes; Lennerstrand, Johan et al.

Part of Virology, 2026

• DOI for Twist-ONT: Combining nanopore sequencing with the twist comprehensive viral research panel

Dynamics of SARS-CoV-2 variants and mutations in Central Sweden between 2023 and 2024 and their potential implications on monoclonal antibodies pemivibart and sipavibart as PrEP in the region

Haars, Jonathan; Wallin, Frans; Elfving, Karin; Jonsson, Anna-Karin et al.

Part of Infectious Diseases, p. 956-965, 2025

• DOI for Dynamics of SARS-CoV-2 variants and mutations in Central Sweden between 2023 and 2024 and their potential implications on monoclonal antibodies pemivibart and sipavibart as PrEP in the region
• Download full text (pdf) of Dynamics of SARS-CoV-2 variants and mutations in Central Sweden between 2023 and 2024 and their potential implications on monoclonal antibodies pemivibart and sipavibart as PrEP in the region

Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries

Akaberi, Dario; Pourghasemi, Monireh; Krambrich, Janina; Berger, Julia et al.

Part of Antimicrobial Agents and Chemotherapy, p. 1-18, 2024

• DOI for Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
• Download full text (pdf) of Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries

From SARS-CoV-2 to Global Preparedness: A Graphical Interface for Standardised High-Throughput Bioinformatics Analysis in Pandemic Scenarios and Surveillance of Drug Resistance

Cumlin, Tomas; Karlsson, Ida; Haars, Jonathan; Rosengren, Maria et al.

Part of International Journal of Molecular Sciences, 2024

• DOI for From SARS-CoV-2 to Global Preparedness: A Graphical Interface for Standardised High-Throughput Bioinformatics Analysis in Pandemic Scenarios and Surveillance of Drug Resistance
• Download full text (pdf) of From SARS-CoV-2 to Global Preparedness: A Graphical Interface for Standardised High-Throughput Bioinformatics Analysis in Pandemic Scenarios and Surveillance of Drug Resistance

Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022–2023

Haars, Jonathan; Palanisamy, Navaneethan; Wallin, Frans; Mölling, Paula et al.

Part of Microorganisms, 2023

• DOI for Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022–2023
• Download full text (pdf) of Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022–2023

Twist-ONT: Combining nanopore sequencing with the twist comprehensive viral research panel

Haars, Jonathan; Cumlin, Tomas; Ladenvall, Claes; Lennerstrand, Johan et al.

Part of Virology, 2026

• DOI for Twist-ONT: Combining nanopore sequencing with the twist comprehensive viral research panel

Dynamics of SARS-CoV-2 variants and mutations in Central Sweden between 2023 and 2024 and their potential implications on monoclonal antibodies pemivibart and sipavibart as PrEP in the region

Haars, Jonathan; Wallin, Frans; Elfving, Karin; Jonsson, Anna-Karin et al.

Part of Infectious Diseases, p. 956-965, 2025

• DOI for Dynamics of SARS-CoV-2 variants and mutations in Central Sweden between 2023 and 2024 and their potential implications on monoclonal antibodies pemivibart and sipavibart as PrEP in the region
• Download full text (pdf) of Dynamics of SARS-CoV-2 variants and mutations in Central Sweden between 2023 and 2024 and their potential implications on monoclonal antibodies pemivibart and sipavibart as PrEP in the region

Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries

Akaberi, Dario; Pourghasemi, Monireh; Krambrich, Janina; Berger, Julia et al.

Part of Antimicrobial Agents and Chemotherapy, p. 1-18, 2024

• DOI for Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
• Download full text (pdf) of Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries

From SARS-CoV-2 to Global Preparedness: A Graphical Interface for Standardised High-Throughput Bioinformatics Analysis in Pandemic Scenarios and Surveillance of Drug Resistance

Cumlin, Tomas; Karlsson, Ida; Haars, Jonathan; Rosengren, Maria et al.

Part of International Journal of Molecular Sciences, 2024

• DOI for From SARS-CoV-2 to Global Preparedness: A Graphical Interface for Standardised High-Throughput Bioinformatics Analysis in Pandemic Scenarios and Surveillance of Drug Resistance
• Download full text (pdf) of From SARS-CoV-2 to Global Preparedness: A Graphical Interface for Standardised High-Throughput Bioinformatics Analysis in Pandemic Scenarios and Surveillance of Drug Resistance

Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022–2023

Haars, Jonathan; Palanisamy, Navaneethan; Wallin, Frans; Mölling, Paula et al.

Part of Microorganisms, 2023

• DOI for Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022–2023
• Download full text (pdf) of Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022–2023

SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing

Mannsverk, Steinar; Bergholm, Julia; Palanisamy, Navaneethan; Ellström, Patrik et al.

Part of Virology Journal, 2022

• DOI for SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing
• Download full text (pdf) of SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

Howe, Anita Y. M.; Rodrigo, Chaturaka; Cunningham, Evan B.; Douglas, Mark W. et al.

Part of JHEP Reports, 2022

• DOI for Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
• Download full text (pdf) of Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses

Luttens, Andreas; Gullberg, Hjalmar; Abdurakhmanov, Eldar; Vo, Duy Duc et al.

Part of Journal of the American Chemical Society, p. 2905-2920, 2022

• DOI for Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
• Download full text (pdf) of Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses

Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein

Lennerstrand, Johan; Palanisamy, Navaneethan

Part of Viruses, 2021

• DOI for Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
• Download full text (pdf) of Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein

SHARED: An International Collaboration to Unravel Hepatitis C Resistance

Howe, Anita Y. M.; Ceccherini-Silberstein, Francesca; Dietz, Julia; Popping, Stephanie et al.

Part of Viruses, 2021

• DOI for SHARED: An International Collaboration to Unravel Hepatitis C Resistance
• Download full text (pdf) of SHARED: An International Collaboration to Unravel Hepatitis C Resistance

Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors

Akaberi, Dario; Bahlstrom, Amanda; Chinthakindi, Praveen K.; Nyman, Tomas et al.

Part of Antiviral Research, 2021

• DOI for Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors

Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro

Akaberi, Dario; Krambrich, Janina; Ling, Jiaxin; Chen, Luni et al.

Part of Redox Biology, 2020

• DOI for Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
• Download full text (pdf) of Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro

Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease

Akaberi, Dario; Chinthakindi, Praveen K.; Båhlström, Amanda; Palanisamy, Navaneethan et al.

Part of Journal of Biomolecular Structure and Dynamics, p. 5526-5536, 2020

• DOI for Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease
• Download full text (pdf) of Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease

Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway

Kjellin, Midori; Kileng, Hege; Akaberi, Dario; Palanisamy, Navaneethan et al.

Part of Scandinavian Journal of Gastroenterology, p. 1042-1050, 2019

• DOI for Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway
• Download full text (pdf) of Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway

A Real World Resistance Profile of Virologic Failures Collected from an International Collaboration (SHARED)

Howe, Anita; Cento, Valeria; Knight, Nathaniel; Dietz, Julia et al.

Part of Hepatology, 2018

The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort

Kjellin, Midori; Wesslén, Terése; Löfblad, Erik; Lennerstrand, Johan et al.

Part of Upsala Journal of Medical Sciences, p. 50-56, 2018

• DOI for The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort
• Download full text (pdf) of The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort

Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antivirals

Palanisamy, Navaneethan; Kalaghatgi, Prabhav; Akaberi, Dario; Lundkvist, Åke et al.

Part of Antiviral Therapy, p. 485-493, 2018

• DOI for Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antivirals

Comparative genome analysis of Alkhumra hemorrhagic fever virus with Kyasanur forest disease and tick-borne encephalitis viruses by the in silico approach

Palanisamy, Navaneethan; Akaberi, Dario; Lennerstrand, Johan; Lundkvist, Åke

Part of Pathogens and Global Health, p. 210-226, 2018

• DOI for Comparative genome analysis of Alkhumra hemorrhagic fever virus with Kyasanur forest disease and tick-borne encephalitis viruses by the in silico approach

Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and Hepacivirus

Palanisamy, Navaneethan; Akaberi, Dario; Lennerstrand, Johan

Part of Molecular Phylogenetics and Evolution, p. 58-63, 2018

• DOI for Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and Hepacivirus

Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.

Kileng, Hege; Kjellin, Midori; Akaberi, Dario; Bergfors, Assar et al.

Part of Scandinavian Journal of Gastroenterology, p. 1347-1353, 2018

• DOI for Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.
• Download full text (pdf) of Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.

Biophysical Studies on HCV 1a NS3/4A Protease and Its Catalytic Triad in Wild Type and Mutants by the In Silico Approach.

Palanisamy, Navaneethan; Lennerstrand, Johan

Part of Interdisciplinary sciences: computational life sciences, p. 143-156, 2018

• DOI for Biophysical Studies on HCV 1a NS3/4A Protease and Its Catalytic Triad in Wild Type and Mutants by the In Silico Approach.

Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance

Bartlett, S. R.; Grebely, J.; Eltahla, A. A.; Reeves, J. D. et al.

Part of Journal of Hepatology, 2017

• DOI for Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance

Computational prediction of Usutu virus E protein B cell and T cell epitopes for potential vaccine development.

Palanisamy, Navaneethan; Lennerstrand, Johan

Part of Scandinavian Journal of Immunology, p. 350-364, 2017

• DOI for Computational prediction of Usutu virus E protein B cell and T cell epitopes for potential vaccine development.

Hepatitis C Genotype 4R Resistance-Associated Polymorphisms: The Achilles Heel of the Nonstructural 5A Inhibitors? Reply

Miller, Veronica; Harrington, Patrick; Howe, Anita; Kieffer, Tara et al.

Part of Hepatology, p. 698-699, 2016

• DOI for Hepatitis C Genotype 4R Resistance-Associated Polymorphisms: The Achilles Heel of the Nonstructural 5A Inhibitors? Reply

Analysis of hepatitis C NS5A resistance associated polymorphisms using ultra deep single molecule real time (SMRT) sequencing

Bergfors, Assar; Leenheer, Daniel; Bergqvist, Anders; Ameur, Adam et al.

Part of Antiviral Research, p. 81-89, 2016

• DOI for Analysis of hepatitis C NS5A resistance associated polymorphisms using ultra deep single molecule real time (SMRT) sequencing

SYBR Green II Dye-Based Real-Time Assay for Measuring Inhibitor Activity Against HIV-1 Reverse Transcriptase

Kokkula, Chakradhar; Palanisamy, Navaneethan; Ericstam, Malin; Lennerstrand, Johan

Part of Molecular Biotechnology, p. 619-625, 2016

• DOI for SYBR Green II Dye-Based Real-Time Assay for Measuring Inhibitor Activity Against HIV-1 Reverse Transcriptase

Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden

Danielsson, Axel; Palanisamy, Navaneethan; Golbob, Sultan; Yin, Hong et al.

Part of Infection Ecology & Epidemiology, 2014

• DOI for Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden

Implications of baseline polymorphisms for potential resistance to NS3 protease and NS5A inhibitors in hepatitis C virus genotypes 1a, 2b and 3a

Lindström, I.; Palanisamy, Navaneethan; Kjellin, M.; Danielsson, Axel et al.

Part of Antiviral Therapy, 2013

Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a

Palanisamy, Navaneethan; Danielsson, Axel; Kokkula, Chakradhar; Yin, Hong et al.

Part of Antiviral Research, p. 12-17, 2013

• DOI for Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a

Homogeneous assay for real-time and simultaneous detection of thymidine kinase 1 and deoxycytidine kinase activities

Stalhandske, Per; Wang, Liya; Westberg, Sara; von Euler, Henrik et al.

Part of Analytical Biochemistry, p. 155-164, 2013

• DOI for Homogeneous assay for real-time and simultaneous detection of thymidine kinase 1 and deoxycytidine kinase activities

Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds

Orozovic, Goran; Orozovic, Kanita; Lennerstrand, Johan; Olsen, Björn

Part of PLOS ONE, 2011

• DOI for Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds
• Download full text (pdf) of Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds

Environmental Levels of the Antiviral Oseltamivir Induce Development of Resistance Mutation H274Y in Influenza A/H1N1 Virus in Mallards

Järhult, Josef D.; Muradrasoli, Shaman; Wahlgren, John; Söderström, Hanna et al.

Part of PLOS ONE, 2011

• DOI for Environmental Levels of the Antiviral Oseltamivir Induce Development of Resistance Mutation H274Y in Influenza A/H1N1 Virus in Mallards
• Download full text (pdf) of Environmental Levels of the Antiviral Oseltamivir Induce Development of Resistance Mutation H274Y in Influenza A/H1N1 Virus in Mallards

Selection and Characterization of HIV-1 with a Novel S68 Deletion in Reverse Transcriptase

Schinazi, Raymond F.; Massud, Ivana; Rapp, Kimberly L.; Cristiano, Meta et al.

Part of Antimicrobial Agents and Chemotherapy, p. 2054-2060, 2011

• DOI for Selection and Characterization of HIV-1 with a Novel S68 Deletion in Reverse Transcriptase

Nya antivirala läkemedel mot hepatit C i kliniska studier: Ger hopp om bot - men resistens-problematiken måste bemästras

Lennerstrand, Johan; Bondeson, Kåre; Bergqvist, Anders; Blomberg, Jonas et al.

Part of Läkartidningen, p. 3254-3260, 2009

Biochemical studies on the mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to 1-(beta-D-dioxolane)thymine triphosphate

Lennerstrand, Johan; Chu, Chung K.; Schinazi, Raymond F.

Part of Antimicrobial Agents and Chemotherapy, p. 2078-2084, 2007

• DOI for Biochemical studies on the mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to 1-(beta-D-dioxolane)thymine triphosphate
• Download full text (pdf) of Biochemical studies on the mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to 1-(beta-D-dioxolane)thymine triphosphate

Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro

Curr, Kenneth; Tripathi, Snehlata; Lennerstrand, Johan; Larder, Brendan A. et al.

Part of Journal of General Virology, p. 419-428, 2006

• DOI for Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro
• Download full text (pdf) of Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro

Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing

Shao, Xing-Wu; Malmsten, Anders; Lennerstrand, Johan; Sönnerborg, Anders et al.

Part of AIDS, p. 1463-1471, 2003

• DOI for Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing

Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation

Meyer, Peter R; Lennerstrand, Johan; Matsuura, Suzanne E; Larder, Brendan A et al.

Part of Journal of Virology, p. 3871-3877, 2003

• DOI for Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation

Application of a colorimetric chain-termination assay for characterization of reverse transcriptase from 3-azido-2,3-deoxythymidine-resistant HIV isolates

Shao, X-W; Hjalmarsson, Sandra; Lennerstrand, Johan; Svennerholm, B et al.

Part of Biotechnology and applied biochemistry, p. 155-164, 2002

• DOI for Application of a colorimetric chain-termination assay for characterization of reverse transcriptase from 3-azido-2,3-deoxythymidine-resistant HIV isolates

Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine

Lennerstrand, Johan; Stammers, D K; Larder, B A

Part of Antimicrobial Agents and Chemotherapy, p. 2144-2146, 2001

• DOI for Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine

Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants

Lennerstrand, Johan; Hertogs, K; Stammers, D K; Larder, B A

Part of Journal of Virology, p. 7202-7205, 2001

• DOI for Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants

The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer

Linderholm, BK; Lindahl, T; Holmberg, Lars; Klaar, S et al.

Part of Cancer Research, p. 2256-2260, 2001

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors.

Norberg, Torbjörn; Lennerstrand, Johan; Inganäs, Mats; Bergh, Jonas

Part of International Journal of Cancer, p. 376-383, 1998

• DOI for Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors.

Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis.

de Witte, H H; Foekens, J A; Lennerstrand, Johan; Smid, M et al.

Part of International Journal of Cancer, p. 125-130, 1996

• DOI for Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis.

A Method for Combined Immunoaffinity Purification and Assay of HIV-1 Reverse Transcriptase Activity Useful for Crude Samples

Lennerstrand, Johan; Rytting, A S; Örvell, C; Gronowitz, J S et al.

Part of Analytical Biochemistry, p. 141-152, 1996

• DOI for A Method for Combined Immunoaffinity Purification and Assay of HIV-1 Reverse Transcriptase Activity Useful for Crude Samples

Prognostic significance of p53 overexpression in primary breast cancer: a novel luminometric immunoassay applicable on steroid receptor cytosols.

Borg, A; Lennerstrand, Johan; Stenmark-Askmalm, M; Fernö, M et al.

Part of British Journal of Cancer, p. 1013-1017, 1995

• DOI for Prognostic significance of p53 overexpression in primary breast cancer: a novel luminometric immunoassay applicable on steroid receptor cytosols.

HIV-1 reverse transcriptase inhibiting antibody titer in serum: relation to disease progression and to core-antibody levels.

Neumüller, M; Karlsson, A; Lennerstrand, Johan; Källander, C F et al.

Part of Journal of Medical Virology, p. 283-291, 1992

• DOI for HIV-1 reverse transcriptase inhibiting antibody titer in serum: relation to disease progression and to core-antibody levels.

Carrier bound templates for single tube reverse transcriptase assays and for combined purification and activity analyses, with special reference to HIV

Gronowitz, J S; Neumüller, M; Lennerstrand, Johan; Bhikhabhai, R et al.

Part of Biotechnology and applied biochemistry, p. 127-142, 1991

• DOI for Carrier bound templates for single tube reverse transcriptase assays and for combined purification and activity analyses, with special reference to HIV

HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables.

Neumüller, Magnus; Karlsson, Anders; Lennerstrand, Johan; Källander, Clas F et al.

Part of Journal of Medical Virology, p. 55-63, 1991

• DOI for HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables.

Sequencing of Hepatitis C Virus for Detection of Resistance to Direct-Acting Antiviral Therapy: A Systematic Review

Bartlett, Sofia R.; Grebely, Jason; Eltahla, Auda A.; Reeves, Jacqueline D. et al.

Part of HEPATOLOGY COMMUNICATIONS, p. 379-390, 2017

• DOI for Sequencing of Hepatitis C Virus for Detection of Resistance to Direct-Acting Antiviral Therapy: A Systematic Review
• Download full text (pdf) of Sequencing of Hepatitis C Virus for Detection of Resistance to Direct-Acting Antiviral Therapy: A Systematic Review

Hepatitis C virus drug resistance-associated substitutions: State of the art summary

Lontok, Erik; Harrington, Patrick; Howe, Anita; Kieffer, Tara et al.

Part of Hepatology, p. 1623-1632, 2015

• DOI for Hepatitis C virus drug resistance-associated substitutions: State of the art summary

Approaches for the development of antiviral compounds: the case of hepatitis C virus

Schinazi, Raymond F.; Coats, Steven J.; Bassit, Leda C.; Lennerstrand, Johan et al.

Part of Antiviral Strategies, p. 25-51, Springer Berlin/Heidelberg, 2009

• DOI for Approaches for the development of antiviral compounds: the case of hepatitis C virus
• Download full text (pdf) of Approaches for the development of antiviral compounds: the case of hepatitis C virus

Assays for reverse transcriptase activity and p53 protein: applications for characterisation of HIV RT mutants and inhibitors and for p53 expression in breast cancer

Lennerstrand, Johan

1996

Determination of Hepatitis C (HCV) Genotypes and Drug Resistances By a Efficient and Cost-effective Sequence Analysis Method: One cDNA synthesis, two assays

Yin, Hong; Lennerstrand, Johan; Bondeson, Kåre

2009

• Download full text (pdf) of Determination of Hepatitis C (HCV) Genotypes and Drug Resistances By a Efficient and Cost-effective Sequence Analysis Method: One cDNA synthesis, two assays

Oseltamivir- and Zanamivir-Resistance Related Mutations in Influenza A Viruses Isolated from Wild Mallards in Sweden Studied by a Colorimetric Neuraminidase Inhibition Assay

Orozovic, Goran; Järhult, Josef D.; Orozovic, Kanita; Tolf, Conny et al.